|
|
| Session 16: Protein and Peptide Drug Development |
|
Session Chair: Dr. Anton Fliri , Research Fellow, Pfizer Inc, USA
Co-Chair: Dr. W.I.M. Van de Ven, Professor, Laboratory for Molecular Oncology, Department of Human Genetics, Belgium |
|
|
Title: Analytical Challenges in Protein Therapeutics Development
Dr. Xing Wang, Senior Principal Scientist, Global Biologics, Pfizer Global Research and Development, USA
|
|
Title: GEP: a Novel Chondrogenic Growth Factor and Target in Arthritis
Dr. Chuanju Liu, Assistant Professor, Dept. of Orthopaedic Surgery & Cell Biology, New York University School of Medicine, USA
|
|
Title: Furin: A Proven Endoproteolytic Processing Tool for Enhanced Manufacturing of Safe Recombinant Biopharmaceuticals
Dr. W.J.M. Van de Ven, Professor, Laboratory for Molecular Oncology, Department of Human Genetics, Belgium
|
|
Title: MED-SuMo : A Powerful Software to Classify Binding Sites Using 3D Surface Chemical Features and to Perform Fragment-Based Drug Design at PDB Scale
Dr. Alexandre G. de Brevern, French Institute of Health and Medical Research, France
|
|
Title: Studies on the Origin of Protein Network Topologies
Dr. Anton Fliri, Research Fellow, Pfizer Inc, USA
|
|
Title: Ribosomal synthesis of unusual peptides by reprogramming the genetic code and its application for physiologically stable peptide drugs
Dr. Hiroaki Suga, Research Center for Advanced Science and Technology, The University of Tokyo, Japan
|
|
Title: In vivo Regulation and Inhibition of Ribonucleotide Reductase
Dr. Mingxia Huang, University of Colorado Health Sciences Center, USA
|
|
Title: Molecular Designer Of Self-assembling Peptide Nanomaterials and Its Application In Regenerative Medicine
Dr. Xiaojun Zhao, Professor and Executive Director, Institute for Nanobiomedical Technology and Membrane Biology, Sichuan University, Chengdu, China |
|